New Post Public Reply Private Reply Replies (1) Message Board ← Newer Older → Churbz83 Sep 1, 2014 at 6:12 PM In your opinion if we see 1. Revenue guidance for 50 million 2015 Lympro 2. Partner for Lympro with 20 million up front 3. Orphan for MANF wolframs/RP in next 60 days is PPS near a buck? Amarantus Bioscience Holdings (AMBS) Stock Research Links AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials Newer Older